Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Non-Current Assets (2019 - 2025)

Korro Bio (KRRO) has disclosed Non-Current Assets for 6 consecutive years, with $63.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Assets fell 30.23% year-over-year to $63.3 million, compared with a TTM value of $316.8 million through Sep 2025, up 13.96%, and an annual FY2024 reading of $94.7 million, up 93.54% over the prior year.
  • Non-Current Assets was $63.3 million for Q3 2025 at Korro Bio, down from $77.8 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $94.7 million in Q4 2024 and bottomed at $3.8 million in Q3 2023.
  • Average Non-Current Assets over 5 years is $51.9 million, with a median of $48.9 million recorded in 2023.
  • The sharpest move saw Non-Current Assets crashed 89.01% in 2023, then surged 2258.02% in 2024.
  • Year by year, Non-Current Assets stood at $50.6 million in 2021, then crashed by 67.08% to $16.7 million in 2022, then soared by 193.75% to $48.9 million in 2023, then skyrocketed by 93.54% to $94.7 million in 2024, then plummeted by 33.14% to $63.3 million in 2025.
  • Business Quant data shows Non-Current Assets for KRRO at $63.3 million in Q3 2025, $77.8 million in Q2 2025, and $81.0 million in Q1 2025.